Amisulpride - CAS 71675-85-9

Amisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban) . Amisulpride is a selective dopamine antagonist.

Dopamine Receptor, 5-HT Receptor

Neuroscience, GPCR/G Protein

71581

0.9999

C17H27N3O4S

369.48

C(NCC1N(CC)CCC1)(=O)C2=C(OC)C=C(N)C(S(CC)(=O)=O)=C2

-20°C

Ice Packs

Small Compound